ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
This Quarter Return
+81.75%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$99.4M
AUM Growth
+$99.4M
Cap. Flow
-$15.6M
Cap. Flow %
-15.66%
Top 10 Hldgs %
60.37%
Holding
49
New
8
Increased
12
Reduced
15
Closed
10

Top Buys

1
DRUG
Bright Minds Biosciences
DRUG
$2.49M
2
TRVI icon
Trevi Therapeutics
TRVI
$1.98M
3
CDTX icon
Cidara Therapeutics
CDTX
$1.46M
4
NAMS icon
NewAmsterdam Pharma
NAMS
$1.29M
5
ZYME icon
Zymeworks
ZYME
$984K

Top Sells

1
PCVX icon
Vaxcyte
PCVX
$7.4M
2
ACLX icon
Arcellx
ACLX
$3.94M
3
KURA icon
Kura Oncology
KURA
$3.85M
4
CMPS
Compass Pathways
CMPS
$2.43M
5
TSHA icon
Taysha Gene Therapies
TSHA
$2.14M

Sector Composition

1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ZYME icon
26
Zymeworks
ZYME
$1.12B
$984K 0.99% +67,240 New +$984K
ELDN icon
27
Eledon Pharmaceuticals
ELDN
$155M
$971K 0.98% +235,750 New +$971K
VERV
28
DELISTED
Verve Therapeutics
VERV
$904K 0.91% 160,200 +14,100 +10% +$79.5K
RARE icon
29
Ultragenyx Pharmaceutical
RARE
$2.89B
$883K 0.89% 21,000 -4,100 -16% -$172K
GILD icon
30
Gilead Sciences
GILD
$140B
$845K 0.85% 9,150 -10,350 -53% -$956K
ACLX icon
31
Arcellx
ACLX
$3.85B
$824K 0.83% 10,743 -51,357 -83% -$3.94M
SGMO icon
32
Sangamo Therapeutics
SGMO
$157M
$755K 0.76% +740,000 New +$755K
THRD
33
DELISTED
Third Harmonic Bio
THRD
$512K 0.52% 49,800 +34,292 +221% +$353K
ARTV
34
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$76.7M
$444K 0.45% 44,000 – –
FBRX icon
35
Forte Biosciences
FBRX
$137M
$412K 0.41% +18,139 New +$412K
CRVS icon
36
Corvus Pharmaceuticals
CRVS
$428M
$398K 0.4% +74,307 New +$398K
CELC icon
37
Celcuity
CELC
$2.17B
$327K 0.33% 25,000 -21,600 -46% -$283K
RAPP
38
Rapport Therapeutics
RAPP
$643M
$291K 0.29% 16,400 -1,200 -7% -$21.3K
NUVB.WS icon
39
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$20.9K 0.02% 90,832 – –
BNTC icon
40
Benitec Biopharma
BNTC
$348M
– – -29,800 Closed -$274K
CMPS
41
Compass Pathways
CMPS
$424M
– – -386,500 Closed -$2.43M
CRBP icon
42
Corbus Pharmaceuticals
CRBP
$115M
– – -18,500 Closed -$382K
DYN icon
43
Dyne Therapeutics
DYN
$1.92B
– – -46,200 Closed -$1.66M
GERN icon
44
Geron
GERN
$893M
– – -154,900 Closed -$703K
KURA icon
45
Kura Oncology
KURA
$686M
– – -197,000 Closed -$3.85M
LPTX icon
46
Leap Therapeutics
LPTX
$12M
– – -120,500 Closed -$310K
SLRN
47
DELISTED
ACELYRIN
SLRN
– – -364,000 Closed -$1.79M
TVTX icon
48
Travere Therapeutics
TVTX
$1.56B
– – -19,000 Closed -$266K
CLYM
49
Climb Bio, Inc. Common Stock
CLYM
$151M
– – -54,000 Closed -$275K
1
2